Financial Performance
5Y price score: 75
The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.
A score of 100 indicates that the stock did as well as the S&P 500 Index.
A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.
10Y return: 227.1%
US$ Per
Share
By default your notes are visible only to you.
67.3
52-week range
100.9
Your model inputs
Your fair value & Margin of safety
To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.
Forecast:
Valuation
Free Cash Flow Yield
29.8 %
Dividend Yield TTM
2.4 %
Market cap $
$ 62,716
Price / Earnings TTM
18.7
Price / Book TTM
2.3
PEG TTM
(1)
Earnings growth and return
LTM
5YR
10YR
Total return (price & dividends)
28.9 %
72.5 %
227.1 %
Free cash flow per share growth
28.1 %
116.1 %
130.2 %
Earnings per share growth
(19.2) %
(15.5) %
5 %
Founded: 1,868
Employees: 45,000
Business Summary:
Latest Earnings Call Takeaways
2026 Q2 (Aug 6, 2026)
1) Strategy & Leadership
- MetLife's New Frontier strategy is effectively driving growth, leveraging two complementary earnings engines: capital light and capital driven.
- The company reported strong performance across all business segments, with adjusted earnings of approximately $1.6 billion, a 15% increase YoY.
- MetLife continues to focus on disciplined capital management, returning over $2.4 billion to shareholders year-to-date through buybacks and dividends.
2) Financial & Segment Results
- Adjusted earnings per share rose 20% to $2.43, with a return on equity of 17%, at the top end of the target range.
- Key segment performances include:
- Group Benefits: Adjusted earnings of $503 million, up 25% YoY, driven by favorable life underwriting and strong sales growth.
- Retirement and Income Solutions (RIS): Adjusted earnings of $377 million, up 2% YoY, with PFOs excluding pension risk transfers increasing 19%.
- Asia: Adjusted earnings of $420 million, a 21% increase, with sales up 17% on a constant currency basis.
- Latin America: Adjusted earnings of $268 million, up 15% YoY, with sales rising 9%.
- EMEA: Adjusted earnings of $108 million, up 8% YoY, with sales increasing 15%.
- MetLife Investment Management (MIM): Adjusted earnings of $57 million, up 6%.
3) Problems / Headwinds
- The company faces potential normalization in mortality ratios, particularly in Group Life, which may impact future underwriting results.
- RIS reported a total investment spread of 97 basis points, below guidance, primarily due to weaker private equity returns.
- The PRT market remains lumpy, with a lighter first half of 2026 compared to a record 2025, but a stronger pipeline is anticipated for the second half.
4) Operational or Product Plans
- MetLife is integrating AI to enhance productivity and customer experience, with expectations for significant long-term benefits.
- The company is exploring inorganic growth opportunities, particularly in asset management and group benefits, while remaining disciplined in capital deployment.
- Continued focus on product innovation, particularly in Asia, with strong sales momentum and a balanced mix of U.S. dollar and yen products.
5) Guidance & Outlook / Investor Angle
- MetLife maintains a positive outlook, expecting to meet or exceed financial commitments for the year.
- The company has a new $3 billion share repurchase authorization, reflecting confidence in its capital generation and long-term prospects.
- The management is optimistic about growth opportunities across all segments, particularly in the context of favorable demographics and market conditions.
Bottom line: MetLife's strong Q2 results and strategic execution under the New Frontier initiative demonstrate resilience and growth potential, making it an attractive investment for shareholders, despite some normalization risks in mortality and market headwinds.
Annual Reports, Presentations And IR Contacts
Go to the websiteMetLife — Financial Overview, Stock Price, Market Cap
MetLife is a company. Founded in 1868. As of August 14, 2026, the company's market capitalization is $62715782849 with a current stock price of $97.47.